Hygieia

Hygieia is a specialty provider of insulin therapy and maker of the d-Nav® Insulin Management Program. The d-Nav program includes an AI-powered application that helps people with type 2 diabetes use insulin in a safe and effective way to control their blood sugar levels. Studies show that nearly 90 percent of people using d-Nav achieve lower A1c within three months. The d-Nav Insulin Management Program was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan.
Active
April 2008
50
Software
B2B

$34,500,000

Series B

December 9, 2021
Funding Round
$5,800,000

Date Announced

Round Stage

Round Size

Lead Investors

December 3, 2021
Series B
$17,000,000

Date Announced

Round Stage

Round Size

Lead Investors

August 5, 2021
Funding Round
$1,800,000

Date Announced

Round Stage

Round Size

Lead Investors

firstime ventures
Firstime Ventures
Venture Capital
2014

Investor

Investor Type

Founded

Funds Raised

Artificial Intelligence

Register Pro to view more

Pro

$50 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export